Optimism for Gilead's drug Remdesivir in treating coronavirus patients may be too premature

Yahoo Finance’s Emily McCormick reports on Gilead Science's drug Remdesivir was used in clinical trials to treat patients infected with COVID-19.

breaks down how the medicine has helped reduce COVID-19 symptoms and led to an increase in discharges at hospitals.


Subscribe to Yahoo Finance:



About Yahoo Finance:

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.



Connect with Yahoo Finance:

Get the latest news:

Find Yahoo Finance on Facebook:

Follow Yahoo Finance on Twitter:

Follow Yahoo Finance on Instagram:

Yahoo Finance,Personal Finance,Money,Investing,Business,Savings,Investment,Stocks,Bonds,FX,Currencies,NYSE,Equities,News,Politics,Market,Markets,Market Movers,Midday Movers,coronavirus,COVID-19,Remdesivir,Gilead Sciences,